$STVN News

Wolfe Research Assumes Stevanato Group at Outperform, Announces Price Target of $21

Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript

Stevanato Group Affirms FY2026 GAAP EPS Guidance of $0.64-$0.69; Sees Sales $1.467B-$1.500B

Stevanato Group Affirms FY2026 Adj EPS Guidance of $0.69-$0.73 vs $0.70 Est; Affirms FY2026 Sales Guidance of $1.467B-$1.500B vs $1.490B Est

Stevanato Gr Q1 Adj. EPS $0.13 Beats $0.12 Estimate, Sales $320.386M Beat $312.910M Estimate

Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN)

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Stevanato Group S.p.A. 2025 Q4 - Results - Earnings Call Presentation

Morgan Stanley Maintains Equal-Weight on Stevanato Group, Lowers Price Target to $19

Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story

Citigroup Maintains Buy on Stevanato Group, Lowers Price Target to $26

Keybanc Maintains Overweight on Stevanato Group, Lowers Price Target to $32

Is It Time To Reassess Stevanato Group (STVN) After The Recent Share Price Rebound

Stevanato Group S.p.A. (STVN) Q4 2025 Earnings Call Transcript

Stevanato Group SpA (STVN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Stevanato Group Q4 Earnings Call Highlights

Stevanato Group S.p.A. Q4 2025 Earnings Call Summary

Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates

Stevanato: Q4 Earnings Snapshot